NewsBite

NeuroScientific Biopharmaceuticals

Advertisement
Neuroscientific Biopharmaceuticals has appointed respected paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer.

NeuroScientific appoints top doctor ahead of stem cell therapy rollout

NeuroScientific Biopharmaceuticals is banking on its new, well-credentialled Perth-based chief medical officer to help the company roll out its innovative stem cell therapy.

  • James Pearson

Latest

Haematology medical scientist Dr Marian Sturm, NeuroScientific’s incoming chief scientific officer, pioneered the development of MSCs in her former role as facility director of Royal Perth Hospital’s Cell and Tissue Therapies centre.

New dawn for NeuroScientific with stem cell acquisition

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

  • Matt Birney
This week’s Bulls N’ Bears ASX Runner of the Week is… Grand Gulf Energy.

ASX Runners: Grand Gulf, Meteoric, Aus Strategic Materials & NeuroScientific

This week’s Bulls N’ Bears ASX Runner of the Week is… Grand Gulf Energy after it acquired an option over a billion-barrel oil prospect off the coast of Namibia.

  • Andrew Todd

Original URL: https://www.brisbanetimes.com.au/topic/nsb-jsa